Korea Investment Partners

Korea Investment Partners (KIP) is a prominent venture capital and private equity firm based in Seoul, South Korea, with over 30 years of experience in the industry. Established in 1986, KIP focuses on investing in innovative companies across various sectors, including biotechnology, healthcare, media, financial technology, and information technology. The firm has a diverse portfolio that includes notable companies such as Kakao, Naver, and YG Entertainment. KIP manages more than 20 venture and private equity funds, with total assets under management amounting to approximately $1.8 billion. In addition to its headquarters in Seoul, KIP operates offices in Shanghai, Beijing, and Sunnyvale, showcasing its commitment to global investment opportunities.

Yer-hyun Baek

CEO and President

Young-bong Cho

Executive Director, Head - Growth Investment Team

Steve Hong

Manager

Sang Hyuk Jang

Associate

Hyeong-sun Jeon

Principal

Dong-yeob Kim

Executive Director

Min-kyu Kim

Director

Yong-Jae Kim

Head of Management Support, MD

Kun-ho Kim

Principal

Won-Bae Lee

Executive Director

Ke Liu

Principal

Yeo-hyun Paek

Chief Executive Officer and President

Minsik Park

Director

Jin-han Park

Senior Principal

Hyeong-jun Park

Principal

Young-ho Park

Senior Principal

Deok-joon Shin

Director

Sung-wook Yoo

Principal

Past deals in Growth Stage

Jenfi

Funding Round in 2023
Jenfi Pte Ltd is a financial technology company based in Singapore that specializes in providing revenue-based financing to small and medium-sized enterprises in Asia. Founded in 2019, Jenfi focuses on assisting digitally-enabled businesses, including e-commerce ventures and high-growth startups, by offering funds to enhance their sales velocity. The company enables these businesses to finance their marketing efforts, inventory needs, and growth initiatives, thereby supporting their development and expansion in a competitive market.

NRISE

Series B in 2022
NRISE is develops MOCI and WIPPY services. NRISE research and develops social media services to bring people the joy of communication.

Innospace

Series B in 2022
Innospace is an aerospace and defense company focused on developing hybrid rocket-powered small satellite launch vehicles. The company aims to provide cost-effective, low-latency, and environmentally friendly launch services tailored for the small satellite market. By utilizing innovative hybrid rocket technology, Innospace is committed to delivering reliable solutions for satellite deployment, catering to the increasing demand for efficient access to space.

Apposter

Series B in 2022
Apposter is a Korean-based interactive solutions company engaged in providing UI development, app development, and mobile business consultancy solutions to its customers. Apposter has released many mobile apps and solutions to the enterprise market including, Fotofly, Life Valley, and Tok Song.

Genieworks

Series B in 2022
Genieworks is pioneering new business with creative ideas and technology.

Toffee Pie

Series B in 2022
Toffee Pie is a retailer of bras in different sizes. They develop bras of different sizes and shapes, enabling customers with different needs to access suitable underwear. They offer a large-cup underwear brand that researches and develops bras for big-breasted girls.

Jaranda

Series B in 2022
Jaranda Co., Ltd. owns and operates a platform that integrates teachers, parents, and students. The company is based in Seoul, South Korea.

Catch Table

Series C in 2022
Operator of a restaurant management platform intended to provide restaurant reservation services. The company's platform helps to book tables in restaurants to manage reservations, enabling customers to search by desired conditions such as date, time, and number of people and make real-time reservations.

Rizzle

Series B in 2022
Rizzle is a 60-second video platform that specializes in talk shows and drama, positioning itself as a leading provider of original short-form content. The platform uniquely integrates creation, distribution, and monetization, allowing users to produce and share videos while also enabling sponsorship opportunities. Rizzle's application leverages artificial intelligence to facilitate the video-making process and fosters a global community of content creators. Users can connect with friends, family, and social media, engaging in creative expression through short series, videos, and reels, all at no cost. This approach not only enhances the user experience but also cultivates a vibrant hub for creative collaboration.

MORAI

Series B in 2022
MORAI Inc. is a company that specializes in developing a simulation platform designed to create three-dimensional virtual environments that closely mimic real road conditions. This platform is utilized to test and enhance autonomous driving algorithms, providing essential verification and validation solutions for autonomous vehicles. Additionally, MORAI offers datasets that support the development of advanced driving algorithms. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an office in San Francisco, California.

Loadcomplete

Series B in 2022
Loadcomplete (로드컴플릿) is a social and mobile game developer in Korea. It develops games such as Tap Tap Heroes, Disco Panda, Bumping Bears, Play Kale, Trino, and Blue Heart for iOS and Android devices. Loadcomplete was founded in December 2009.

AIONCO KOREA Co

Series B in 2021
AIONCO KOREA provides competitive item sourcing and logistics solution service to cross border eCommerce clients. AIONCO specializes in the delivery of exceptional Multi-Channel Fulfillment solutions. From pallets to beautifully gift wrapped packages, they provide a streamlined, single-source solution that optimizes the supply chain across all channels for brands in both the direct-to-consumer and wholesale arenas. The company was established in 2015 and is based in Seoul, Korea.

Spatial

Series B in 2021
Spatial Systems, Inc. is a New York-based company founded in 2016 that offers an augmented workplace platform designed to enhance collaboration and productivity. The platform enables users to conduct meetings using spatial audio and 3D telepresence, facilitating a more immersive interaction. It also allows for the sharing and organization of various digital content, such as 3D models, videos, documents, images, and websites, effectively transforming traditional work environments into dynamic digital workspaces. By leveraging cutting-edge technology, Spatial aims to empower individuals and organizations to unlock their creative potential and improve connectivity. The company has attracted investment from notable venture firms and angel investors, underscoring its innovative approach within the augmented reality and virtual reality sectors.

Viron Inc.

Series B in 2021
OncoMyx Therapeutics, Inc. is a biotechnology company specializing in the development of oncolytic immunotherapies utilizing the myxoma virus (MYXV) to stimulate immune responses against cancer. Founded in 2018 and based in Phoenix, Arizona, the company focuses on targeting both hematologic and solid tumors through its innovative MYXV platform. This platform employs a novel systemic delivery method that allows the myxoma virus to be carried by human leukocytes, enabling it to effectively infect tumor cells. By assembling a highly skilled team in oncolytic virus research, OncoMyx aims to advance a pipeline of therapeutic options designed to improve outcomes for cancer patients.

Viron Inc.

Series B in 2021
OncoMyx Therapeutics, Inc. is a biotechnology company specializing in the development of oncolytic immunotherapies utilizing the myxoma virus (MYXV) to stimulate immune responses against cancer. Founded in 2018 and based in Phoenix, Arizona, the company focuses on targeting both hematologic and solid tumors through its innovative MYXV platform. This platform employs a novel systemic delivery method that allows the myxoma virus to be carried by human leukocytes, enabling it to effectively infect tumor cells. By assembling a highly skilled team in oncolytic virus research, OncoMyx aims to advance a pipeline of therapeutic options designed to improve outcomes for cancer patients.

PDC*line Pharma

Series B in 2021
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

ONDA

Series B in 2021
T Port Inc. is an accommodation management platform. T Port Inc.'s real-time reservation management book can easily manage all bookings on the computer or smartphone anytime, anywhere.

Aulton

Series B in 2021
Aulton New Energy Automotive Technology Co., Ltd. specializes in developing battery swapping technology for electric vehicles in China. Headquartered in Shanghai, with an additional office in Guangzhou, the company manufactures equipment for quick battery exchanges and manages power stations that facilitate the installation of batteries in taxis and vehicles used for car-hailing services. Aulton also offers energy management services and has created an automated chassis replacement system that allows for the disassembly and installation of batteries in a fully automated environment, significantly reducing the time required for battery replacement to just a few minutes.

Sellerhub

Series B in 2021
Seller Hub Co., Ltd provides solutions for shopping malls. The company provides solutions such as self contract event, hub X Koolmin card, courier contract, amd hub X coupang. Seller Hub Co., Ltd was incorporated in 2012 and is based in Seoul, South Korea.

Eyevensys

Series B in 2021
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

Trenbe

Series B in 2021
Trenbe Inc. sells apparel, bags, shoes, and accessories online for men and women. The company was incorporated in 2016 and is based in Seoul, South Korea.

Univercells

Series C in 2020
Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

Prokarium

Series B in 2020
Prokarium is a biopharmaceutical company based in London, United Kingdom, specializing in the development of innovative vaccination and cancer immunotherapy solutions through synthetic biology. Founded in 2007, Prokarium focuses on creating targeted vaccines that generate broad immune responses, including mucosal, systemic, and cellular immunity. Their product portfolio includes Vaxonella, which is designed to effectively stimulate immune responses by traversing the gastrointestinal tract, as well as vaccines for various infectious diseases such as Clostridium difficile, Chlamydia trachomatis, plague, and typhoid fever. Prokarium's research aims to enhance the safety and immunogenicity of its bivalent vaccine candidates, contributing to advancements in both infectious disease prevention and cancer treatment.

EVOS eSports

Series B in 2020
EVOS eSports, established in 2016 and based in Jakarta, Indonesia, is a prominent eSports organization that manages competitive teams across various games, including Dota 2, League of Legends, and Arena of Valor. The company is focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. This platform is designed to support professional players and content creators by providing essential infrastructure, enabling them to establish a reputation for professionalism in competitive gaming. EVOS eSports offers comprehensive support for its teams, which includes in-game coaching, training facilities, and mental wellness care. In addition to its team management, the organization also retails merchandise such as t-shirts, bands, caps, and lanyards through its online store.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Cashkaro

Series B in 2020
Cashkaro is India's Largest Cashback & Coupons site. They are backed by Mr. Ratan Tata & one of India's leading VC firms, Kalaari Capital. With over 2 million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Paytm etc. With CashKaro.com you can now EARN CASHBACK every time you shop online with retailers like Paytm, Jabong, Shopclues, Nykaa & 1500 more! Just visit CashKaro.com and then go to the website/s of your choice from here. All you need to do is shop normally & Cashback will be auto applied on checkout. When you visit retailers via CashKaro.com and shop online, retailers pay them commission and from this commission they pay you Cashback. They work with over 1500+ top websites in India and you can earn Cashback on almost all of them. They have partnered with Amazon.in, Flipkart, Nearbuy, ShopClues, Zivame, Dominos, MakeMyTrip & so many more.

Gaussian Robot

Series B in 2020
Gaussian Robot, founded in 2013 and headquartered in Shanghai, China, specializes in the development and manufacture of commercial automatic sweeping robots. The company offers a range of products, including commercial cleaning robots, unmanned sanitation vehicles, security robot solutions, and building distribution robots. Gaussian Robot utilizes advanced technologies, such as simultaneous localization and mapping (SLAM), to enhance the capabilities of its autonomous robots. These innovations cater to various commercial applications, providing effective solutions for cleaning, surveillance, and facility management within the robotics industry.

eBrace

Series B in 2020
Guangzhou eBrace Biotechnology Co., Ltd. specializes in the research, development, production, and sale of orthodontic biological materials and digital 3D printing technologies. Founded in 2010 and headquartered in Guangzhou, China, the company offers a range of products including 3D custom printed orthodontic teeth, dentures, and personalized lingual and bracketless invisible appliances. eBrace is committed to providing detailed and accurate dental solutions, leveraging advanced 3D printing equipment to meet the needs of its customers in the orthodontics sector.

Laundrygo

Series B in 2020
Laundrygo is a on-demand laundry service.

Medizen Humancare

Series B in 2020
MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea.

Rabbit Care

Series B in 2020
Rabbit Care is your first choice for insurance and banking advise. We provide great customer experience through our digital platform and customer care center.

Seculetter

Series B in 2020
SecuLetter Co.,Ltd. develops, manufactures, and markets cyber security appliances to detect unknown attacks with hybrid approaches. Its products include SecuLetter Email (SLE), a threat analysis protection solution for email that blocks cyber attacks which use malicious code; and SecuLetter FileServer (SLF), a threat analysis protection solution for fileserver that blocks the attack via attachment which targets organization that shares files server for co-work. The company was founded in 2015 and is based in Seongnam-si, South Korea.

Longmao Data

Series B in 2020
Longmao Data specializes in offering data services intended for artificial intelligence platforms. It collects images, texts, voices, and videos then utilizes crowdsourcing to annotate the data. The big data is then provided to clients that are in the artificial intelligence field, enabling them to train their AI models. The company was founded in 2014 and is headquartered in Beijing, China.

PDC*line Pharma

Series B in 2020
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Happyeasygo

Series B in 2019
HappyEasyGo is an India based local Online Travel Company. We are providing best air tickets and hotels with the lowest Price. Now you can book various airline tickets such as IndiGo, Jet airways, Go air, Spice Jet, air Asia, Vistara and Air India. We also provide you updated and verified Happy Easy Go instant discount hotels and special offers on flight tickets.

Seculetter

Series B in 2019
SecuLetter Co.,Ltd. develops, manufactures, and markets cyber security appliances to detect unknown attacks with hybrid approaches. Its products include SecuLetter Email (SLE), a threat analysis protection solution for email that blocks cyber attacks which use malicious code; and SecuLetter FileServer (SLF), a threat analysis protection solution for fileserver that blocks the attack via attachment which targets organization that shares files server for co-work. The company was founded in 2015 and is based in Seongnam-si, South Korea.

Newlinks Technology

Series C in 2019
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

Newlink

Series C in 2019
Newlink primarily operates as a digital energy service provider. It promotes energy change, the energy Internet of Things EIoT, and an energy new retail platform. It is a dual-material unicorn at home and abroad, one of the world's top 500 new energy companies, with more than 3,000 employees. Covering oil, electricity, hydrogen, and gas multiple energy categories, opening up the upstream and downstream of the energy industry chain, and digitally reconstructing the energy ecology.

N3TWORK

Series C in 2019
N3TWORK Inc. is a mobile game creator and publisher that focuses on developing free-to-play games for iOS and Android platforms. Founded in 2012 and based in San Francisco, California, the company aims to provide engaging gaming experiences tailored to users' interests. In addition to game development, N3TWORK specializes in networking software that delivers a personalized online experience, allowing seamless integration across various internet devices. The company was formerly known as N3tw0rk, Inc. before rebranding in 2013.

Ansun BioPharma

Series B in 2019
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus. The company was founded in 2003 and is headquartered in San Diego, California.

Crowdworks

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.
Pavilion Data Systems Inc. specializes in the design and development of NVMe-over-Fabric storage platforms that cater to massively-parallel applications. The company offers innovative solutions, including OPENCHOICE, which revolutionizes traditional storage procurement and deployment methods, and Pavilion Data OS, enabling Internet and SaaS companies, cloud service providers, and enterprises to efficiently manage critical applications. Pavilion's products deliver exceptional storage performance and density while avoiding the complexities associated with legacy all-flash arrays. By utilizing Hyperparallel Flash Arrays, which incorporate multiple controllers to maximize the advantages of flash technology, Pavilion achieves ultra-low latency and linear scalability, addressing the growing demand for enhanced data throughput across various sectors, including financial services, government, media, and research. Founded in 2011 and headquartered in San Jose, California, Pavilion Data Systems also maintains offices in Schiphol, the Netherlands, and Pune, India.

Happyeasygo

Series B in 2019
HappyEasyGo is an India based local Online Travel Company. We are providing best air tickets and hotels with the lowest Price. Now you can book various airline tickets such as IndiGo, Jet airways, Go air, Spice Jet, air Asia, Vistara and Air India. We also provide you updated and verified Happy Easy Go instant discount hotels and special offers on flight tickets.

OncXerna Therapeutics

Series B in 2019
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.

Tapas Media

Series B in 2019
Tapas Media, Inc. owns and operates, Tapastic, an online platform and community for indie comic artists and visual storytellers. It specializes in creating visual stories online. The company was founded in 2012 and is based in San Francisco, California.

Hisense Bio

Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

GlowRoad

Series B in 2019
GlowRoad is a social selling platform that provides earning opportunities for Indian women and small businesses. The mobile app allows online retailers and SMEs to earn money by promoting selected goods and services in their online and offline social network.

wadiz

Series C in 2019
Wadiz Corp. operates a crowdfunding platform for start ups. The company was incorporated in 2012 and is based in Seongnam, South Korea.

M.Monstar

Series C in 2019
Developer of a corporate SI platform designed to offer a modular tool. The company offers omnichannel and mobile SCM to build SI large shopping malls in a short period, enabling clients to integrate shopping mall management.

Halodoc

Series B in 2019
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

Frequency Therapeutics

Series B in 2019
Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, dedicated to leveraging the body's natural biology to repair or reverse damage from various degenerative diseases. The company employs a unique Progenitor Cell Activation approach, utilizing combinations of small molecules to stimulate progenitor cells to regenerate functional tissue. Its lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at addressing the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is developing therapies for a variety of degenerative conditions, including multiple sclerosis and ailments affecting muscle, skin, gastrointestinal tract, and bone health. The company has also established a collaboration agreement with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics is focused on disease modification through innovative therapeutic strategies.

Immotor

Series B in 2018
Immotor is a company based in Shenzhen, China, that specializes in the development and sale of portable and personal transport systems. Founded in 2016, the company offers a range of innovative products, including the Immotor GO, a portable motorized scooter, and the Immotor Super Battery, which serves as a power management source. Additionally, Immotor provides the Immotor Cloud, a tool for remote control and fleet management of the Immotor GO. The company also focuses on intelligent battery swapping systems and offers battery-as-a-service solutions for electric motorcycles and lightweight electric vehicles. Immotor is committed to promoting cleaner energy and zero emissions through its advanced technologies and products designed for outdoor activities.

Fresh Your Life

Series B in 2018
Beijing Xianlife E-Commerce is a private company engaged in business-to-consumer food e-commerce. The company is based in China.

AppOnboard

Series B in 2018
AppOnboard is a Los Angeles-based software company empowering creators to build businesses without any programming experience. The company offers two no-code products: Buildbox, the largest no-code mobile game engine, and AppOnboard Studio, a mobile, interactive design studio that enables anyone to create playable ads and app prototypes.
Compare88 gives you the best choices to fulfill your financial and insurance needs in a fast, easy, and secure way. Sign up to receive updates about our products and services.

Univercells

Series B in 2018
Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

Riiid

Series B in 2018
Riiid, established in 2014, is a leading provider of AI tutor solutions that aims to transform the education market through innovative AI technology. The company launched its first commercial product, Santa TOEIC, in 2017, which utilizes a deep learning algorithm and has attracted over one million users in South Korea, demonstrating significant effectiveness. Riiid's AI solutions are designed to replace traditional textbooks and lectures, offering personalized tutoring that surpasses the performance of human tutors while being cost-effective. The company operates Santa TOEIC in Japan and has introduced Santa SAT in Vietnam, with plans for further expansion into new testing areas and geographical markets. By providing adaptive assessment platforms that deliver personalized feedback and targeted learning resources, Riiid empowers students to identify their strengths and weaknesses, track their progress, and achieve their educational goals. Through its efforts, Riiid is driving the democratization of education and reshaping the learning landscape.

StyleShare

Series C in 2018
StyleShare is a realtime mobile and online platform that allows users to share and receive updates on fashion and beauty. With millions of users from 120 different countries, StyleShare is the top mobile platform for those interested in everyday fashion and beauty. Based in Seoul, South Korea, StyleShare has garnered the attention of VOGUE, Instyle, and Elle Japan as the No. 1 mobile fashion application.

Tiki

Series C in 2018
Tiki Corporation retails books, electronics, home appliances, gifts, fashion, beauty, and health products. The company also offers phone, digital equipment and accessories, electrical appliances, life house products, beauty and health products, stationery, vehicles, toys and souvenirs, mother and baby sports products, air ticket booking, and international goods. It sells its products through online store. The company was founded in 2010 and is based in Ho Chi Minh City, Vietnam.

Enlivex Therapeutics

Series B in 2017
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company based in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. Established in 2005 by Professor Dror Mevorach, the company is advancing its lead product candidate, Allocetra, which is currently undergoing several clinical trials. Allocetra is being tested in Phase IIb trials for severe sepsis, as well as in investigator-initiated Phase II trials for treating severe and critical COVID-19 cases and for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. The company is also exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. Enlivex aims to enhance cancer treatment efficacy by combining its cell-based therapy with existing therapies targeting solid tumors, including chimeric antigen receptor T-cell therapy. The company's innovative approach leverages the body's natural mechanisms to promote immune tolerance by utilizing apoptotic cells to interact with dendritic cells, thereby reducing inflammation and autoimmunity.

Woman’s Talk

Venture Round in 2017
Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.

Eloxx

Series C in 2017
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.

Twiggle

Series B in 2017
Twiggle Ltd. develops a search technology that allows a search engine mimic a salesperson. It offers a natural language analyzer that uses natural language processing to extract linguistic intent from customer queries and a universal product ontology for product search. The company provides Twiggle's Semantic API, a plug-and-play semantic search application programming interface (API) that integrates into existing search engines and provides a natural language layer that allows search engineers and data scientists to enhance search logic and present results to shoppers. Twiggle Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel with an additional office in New York, New York.

Appota

Series C in 2017
Appota Corp. is a leading technology firm in Vietnam, established in 2011 and headquartered in Hanoi, with additional offices in Ho Chi Minh City, Jakarta Pusat, and Singapore. The company specializes in mobile platforms for game publishing, advertising, and payment solutions. Its key offerings include Gamota, a mobile game publishing service; Adsota, an advertising platform; and AppotaPay, a comprehensive payment solution. Additionally, Appota operates onClan, a social network for mobile gamers. The company is recognized for its contributions to digital entertainment, online content production, and e-sports, and it regularly publishes market reports that provide insights into mobile, advertising, fintech, and e-sports sectors. Appota has successfully completed three investment rounds and has attracted funding from various investors across Asia, enhancing its capacity to promote foreign investment in the region. With four subsidiaries, including Kdata for cloud solutions, Appota continues to advance its technology solutions and digital content distribution.

ABL Bio

Series B in 2017
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea, dedicated to the development of therapeutic drugs targeting immuno-oncology and neurodegenerative diseases. The company's drug pipeline includes ABL001, an innovative cancer immunotherapy, as well as antibody-drug conjugates (ADCs) and ABL301. ABL Bio aims to improve patient lives through collaboration and innovation, focusing on novel therapies that address significant medical needs in these challenging disease areas.

Elastagen

Series B in 2016
Elastagen Pty Ltd., a clinical stage medical company, produces and sells products based on the human protein tropoelastin. The company offers injectable dermoaesthetic products, stretch mark products, scar revision and wound healing products, and sealant and osteoskeletal products for applications areas, including skin rejuvenation, scar remodeling, and tissue repair. It sells its products through online orders. Elastagen Pty Ltd. was founded in 2003 and is based in Eveleigh, Australia with production operations in Europe; and clinical operations in the United Kingdom. As of April 6, 2018, Elastagen Pty Ltd. operates as a subsidiary of Allergan plc.

KAHR medical

Series B in 2015
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

KAHR medical

Series B in 2015
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

Drama & Company

Series B in 2015
Drama & Company offers applications for developing mobile business cards. The company provides an application and web service Profeel.me, a mobile business card service which lets users to make and share their own cards via smartphone while storing cards from others. Cards made via the application include images, a profile and social media links, and they can be shared via text or other platforms such as Kakao Talk. It also provides a mobile application such as Remember app that helps users to scan, sort, and store all of your business cards in one place. The company is based in Seoul, South Korea.

Super Evil Mega Corp

Series B in 2015
Super Evil Megacorp develops core games for tablet, mobile, and emerging platforms. The company's gaming platform offers video games on mobiles and tablets, enabling users to play single or multiple player game with special effects.

Fronto

Series B in 2015
Fronto is the world’s first mobile lock screen media, which displays curated articles, hot new apps and deals & promos to mobile users through the everyday lock screen in a perfectly seamless way. By simply waking up your phone, you can read trending articles, earn rewards, download coupons, learn new promotional deals. Our first product, Cashslide, was launched in Korea in Nov 2012, and it now has 14 mil users, 2.5 mil DAU and 150 mil PV, which makes it as the most preferred mobile ad channel among local advertisers. In Jul 2013, just 8 months after the launch, we successfully raised $4 mil in Series-A funding. In Apr 2015, we raised $14 mil in Series-B funding. We launched Fronto in the US in May 2014 and hit #1 in New Top Free in Lifestyle. We are looking for experienced mobile media professionals. Join us as a founding member of Fronto based in the SF Bay Area. We are redesigning everyday mobile experience. For more details, visit www.fronto.co and check our app here bit.ly/1ocOJKg

Ujipin

Series B in 2015
Ujipin is a web-based platform that focuses on lifestyle brands. It was launched in 2011. Ujipin is operated from Beijing, China.

SMATOOS

Series B in 2015
SMATOOS (스마투스) is a Korean edtech startup that develops educational services including BeNative, BeNative Pro, and CashEnglish. BeNative Pro, launched in 2015, is the #1 English-learning service in Asia. It is currently being used by Samsung, LG, and over 2000 other companies and universities. BeNative, available on both iOS and Android devices, was released in July 2016 as a free download. Users get access to all content for free, while also being rewarded with weekly cash prizes generated from video ads. It's time to be rewarded for learning! The summer of 2016 also saw the release of CashEnglish and CashSpanish. These apps gamify language learning by also rewarding users with cash rewards. No risks involved. Just Play, Learn, Win! SMATOOS is a portmanteau of Koreanized English words meaning to "study smarter."

MCube

Series C in 2014
mCube, Inc. develops MEMS motion sensors and software solutions. It offers sensor components, sensor modules, and wearable sensor systems. The company’s products are used to measure, monitor, and analyze motion and context in space and generating massive amounts of data/insight. It offers products to customers online and through sales offices and distributors in the United States and internationally. Its products are used in Internet of Moving Things, wearable, hearable, medical, smartphone and tablets, 3d character animation, and human motion measurement. The company was founded in 2009 and is based in San Jose, California. It has locations in Hsinchu and Taipei, Taiwan; and Shenzhen and Shanghai, China.

EuBiologics Co., Ltd.

Series B in 2014
EuBiologics Co., Ltd. is a biopharmaceutical company based in Seoul, South Korea, focused on developing and supplying vaccines aimed at addressing epidemics and antibiotic resistance. The company offers Euvchol, an oral cholera prevention vaccine, and CRM197, a diphtheria toxin mutant vaccine. In addition to its vaccine development, EuBiologics provides customized services for biopharmaceuticals derived from mammalian and microbial cells, which includes cell line development, GMP production, validation, and regulatory support. The company operates facilities for the manufacture of protein-based therapeutics and antibodies, specializing in recombinant biological products and antibody therapeutics. Furthermore, EuBiologics offers services in process, formulation, and analytical method development, along with contract testing services that encompass lot release, stability, raw material, and method validation testing. Founded in 2010, EuBiologics is committed to contributing to global public health through its innovative solutions.

Crossbar

Series C in 2014
Crossbar Inc. is a startup based in Santa Clara, California, specializing in the development and licensing of resistive RAM (ReRAM) technology for data storage. Founded in 2008, the company aims to revolutionize the electronics industry by providing a new class of non-volatile memory that enables significant advancements in performance and energy efficiency. Their innovative ReRAM technology allows for up to one terabyte of storage on a chip the size of a postage stamp, making it suitable for a wide range of applications, including consumer electronics, mobile devices, enterprise storage, and cloud computing. Crossbar's solutions facilitate the integration of computing and storage subsystems, enabling designs that overcome the limitations of traditional flash and DRAM memory. The company's focus on persistent and cognitive memory supports advancements in both edge and cloud computing, positioning it at the forefront of the evolving data storage landscape.